APA (7th ed.) Citation

CM, C., AN, S., PT, G., H, A., KH, B., JM, F., . . . A, A. (2024). FLT3 inhibitors potentially improve response rates in acute myeloid leukemia harboring t(6;9)(DEK: :NUP214): the Mayo Clinic experience. Haematologica, 109(11), 3785. https://doi.org/10.3324/haematol.2024.285359

Chicago Style (17th ed.) Citation

CM, Csizmar, et al. "FLT3 Inhibitors Potentially Improve Response Rates in Acute Myeloid Leukemia Harboring T(6;9)(DEK: :NUP214): The Mayo Clinic Experience." Haematologica 109, no. 11 (2024): 3785. https://doi.org/10.3324/haematol.2024.285359.

MLA (9th ed.) Citation

CM, Csizmar, et al. "FLT3 Inhibitors Potentially Improve Response Rates in Acute Myeloid Leukemia Harboring T(6;9)(DEK: :NUP214): The Mayo Clinic Experience." Haematologica, vol. 109, no. 11, 2024, p. 3785, https://doi.org/10.3324/haematol.2024.285359.